[PDF] Top 20 Diseño de una fuente de iones por medio de un reactor de plasma
Has 10000 "Diseño de una fuente de iones por medio de un reactor de plasma" found on our website. Below are the top 20 most common "Diseño de una fuente de iones por medio de un reactor de plasma".
Limited Utility of Dried Blood and Plasma Spot Based Screening for Antiretroviral Treatment Failure with Cobas Ampliprep/TaqMan HIV 1 Version 2 0
... in plasma were analyzed descrip- tively with corresponding detection rates of the CAP/CTM in DBS and DPS among DBS/DPS prepared from the plasma specimens in each stra- ...paired plasma-DBS or ... See full document
18
Evaluation of Quantification of HIV 1 RNA Viral Load in Plasma and Dried Blood Spots by Use of the Semiautomated Cobas Amplicor Assay and the Fully Automated Cobas Ampliprep/TaqMan Assay, Version 2 0, in Kisumu, Kenya
... The utility to use the CAP/CTM and DBS specimens among pa- tients receiving ART therefore was not ...from HIV-infected patients during treatment is ...pregnant HIV-infected females were en- ... See full document
50
Performance of a Novel Low Cost, Instrument Free Plasma Separation Device for HIV Viral Load Quantification and Determination of Treatment Failure in People Living with HIV in Malaysia: a Diagnostic Accuracy Study
... ABSTRACT HIV viral load (VL) testing is the recommended method for monitor- ing the response of people living with HIV and receiving antiretroviral therapy ...standard plasma VL testing in ... See full document
96
Higher Specificity of Nucleic Acid Sequence Based Amplification Isothermal Technology than of Real Time PCR for Quantification of HIV 1 RNA on Dried Blood Spots
... Dried blood spots (DBS) are widely proposed as a plasma surrogate for monitoring antiretroviral treatment efficacy based on the HIV-1 RNA level (viral load [VL]) in ... See full document
77
Evaluation of the Abbott m2000 RealTime Human Immunodeficiency Virus Type 1 (HIV 1) Assay for HIV Load Monitoring in South Africa Compared to the Roche Cobas AmpliPrep Cobas Amplicor, Roche Cobas AmpliPrep Cobas TaqMan HIV 1, and BioMerieux NucliSENS EasyQ HIV 1 Assays
... received antiretroviral (ARV) treatment as part of the national program (24a, ...monitor treatment, determine the prognosis and the risk of disease progression, and identify treatment failures ... See full document
105
Systematic Review of the Performance of HIV Viral Load Technologies on Plasma Samples
... available HIV VL ...Monitor HIV-1 v1.5 (n = 25), Cobas TaqMan ...RealTime HIV-1 (n = 23), Versant HIV-1 RNA bDNA ...Versant HIV-1 RNA kPCR 1.0 ... See full document
84
Evaluation of dried blood spot technique for pharmacokinetic study of hydrochlorothiazide andcomparison of human plasma versus dried blood spot.
... The dried blood spot (DBS) technique is a convenient alternative sample collection method to ...human plasma and DBS samples were developed and ...from plasma were compared against ... See full document
7
Evaluation of the Aptima HCV Quant Dx Assay Using Serum and Dried Blood Spots
... Aptima HCV Quant Dx assay. The Aptima HCV Quant Dx assay (Aptima HCV) was performed on the automated Panther System (Hologic Inc., San Diego, CA). Aptima HCV is U.S. Food and Drug Adminis- tration (FDA) approved for the ... See full document
38
Impact of Early Antiretroviral Therapy on Detection of Cell Associated HIV 1 Nucleic Acid in Blood by the Roche Cobas TaqMan Test
... acute HIV infection were selected from participants of the RV254/SEARCH010 acute HIV-1 infection study conducted at the Thai Red Cross in Bangkok, Thailand ...with HIV subtype ...detectable ... See full document
49
Comparison of an In House Quantitative Real Time PCR and COBAS AmpliPrep/TaqMan Roche for Determination of Viral Load for HIV Type 1 Non B
... [7] Rouet, F., Chaix, M.L., Nerrienet, E., Ngo-Giang-Huong, N., Plantier, J.C., Burgard, M., Peeters, M., Damond, F., Koumavi, E.D., Msellati, P., Ferradini, L., Rukobo, S., Maréchal, V., Schvachsa, N., Wakrim, L., ... See full document
238
Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2 0
... Analytical Sensitivity (Lower Limit of Quantitation, LLoQ) The LLoQ was determined by testing dilutions of the WHO 2nd International Standard for Hepatitis C Virus RNA (NIBSC 96/798, genotype 1) in HCV negative ... See full document
30
Separation of Plasma from Whole Blood by Use of the cobas Plasma Separation Card: a Compelling Alternative to Dried Blood Spots for Quantification of HIV 1 Viral Load
... While plasma is the preferred sample type, viral load measurement from plasma is currently challenging in many ...transporting plasma samples to centralized testing facilities and the need for ... See full document
51
Multicenter Performance Evaluation of a New TaqMan PCR Assay for Monitoring Human Immunodeficiency Virus RNA Load
... The COBAS AMPLICOR HIV-1 MONITOR (CAHIM) test ...of HIV-1 RNA with this assay requires two sample preparation procedures: in the first, ultrasensitive method, 500 l of plasma ... See full document
10
Impact of the New Abbott mPLUS Feature on Clinical Laboratory Efficiencies of Abbott RealTime Assays for Detection of HIV 1, Hepatitis C Virus, Hepatitis B Virus, Chlamydia trachomatis, and Neisseria gonorrhoeae
... conditions. HIV-1-, HCV-, and HBV-positive samples were obtained from either PromedDx (Norton, MA) or Northwest Biomedical (Everett, ...at 2 to 8°C between ...HBV plasma samples (56 ... See full document
93
Performance of the Cobas AmpliPrep/Cobas TaqMan Real Time PCR Assay for Hepatitis B Virus DNA Quantification
... This analysis of the intrinsic performance of the CAP/CTM HBV DNA quantification assay shows its excellent specificity. The CAP/CTM assay was also precise and reproducible, as previously reported (2, 5, 13). ... See full document
190
COBAS AmpliPrep COBAS TaqMan Hepatitis B Virus (HBV) Test: a Novel Automated Real Time PCR Assay for Quantification of HBV DNA in Plasma
... in plasma, even with the most sensitive methods, such as CAP- CTM, leaving open the question of how to detect occult-HBV carriers in important settings such as blood donations, apart from the presence of ... See full document
191
The Use of Dried Blood Spot Samples in Screening Drugs of Abuse
... this screening including urine, blood, saliva, sweat, hair and nails ...of HIV, hepatitis and other blood born viruses ...years, dried blood spots have received consider- able ... See full document
76
Field Evaluation of a Broadly Sensitive HIV 1 In House Genotyping Assay for Use with both Plasma and Dried Blood Spot Specimens in a Resource Limited Country
... genotype HIV-1 sub- type B viruses, which makes them less sensitive in genotyping HIV-1 variants in geographic areas where non-B subtypes and circulating recombinant forms (CRFs) are ... See full document
128
Use of Dried Blood Spot to Improve the Diagnosis and Management of HIV in Resource Limited Settings
... DBS stored at room temperature can remain stable for optimum performance up to an average of 14 days (2 weeks) before starting to lose the quality of material that are deposited [12,16,25]. Bertagnolio et al., and ... See full document
56
Performance Evaluation of the New Roche cobas AmpliPrep/cobas TaqMan HCV Test, Version 2 0, for Detection and Quantification of Hepatitis C Virus RNA
... between the test platforms except for lower values of the Realtime test on the WHO international standard and the Acrometrix Op- tiqual genotype 2 sample. The performance of the CAP/CTM v1.0, CAP/CTM v2.0, ... See full document
43
Related subjects